Encrypted | Login

2015 AAPM Annual Meeting - Session: Point/Counterpoint: Biological Dose Optimization



Treatment Planning Evaluation and Optimization Should Be Biologically and Not Dose/volume Based
Joseph Deasy, PhD Memorial Sloan Kettering Cancer Center
deasyj@mskcc.org


When you have finished the video, you may watch again, browse/search all videos, go back to the previous page, or watch another video in this session (see below). add this video to a playlist.



All videos in this session:
Treatment Planning Evaluation and Optimization Should Be Dose/volume and Not Biologically Based - Charles Mayo, PhD Mayo Clinic
Biological Treatment Planning - Colin Orton, PhD Wayne State University
Q & A -
Graph includes 421 member loads and excludes non-members. Include? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.